Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesInvestment Gain (Loss)Net Income towards Common StockholdersNon-Interest IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - AccuredReceivables - NetShares OutstandingShares Outstanding
Ratios

Global Indemnity (GBLI) Cost of Revenue (2016 - 2025)

Global Indemnity has reported Cost of Revenue over the past 13 years, most recently at $49.9 million for Q3 2025.

  • For Q3 2025, Cost of Revenue fell 4.82% year-over-year to $49.9 million; the TTM value through Sep 2025 reached $35.8 million, up 174.04%, while the annual FY2024 figure was $25.7 million, 9.89% up from the prior year.
  • Cost of Revenue for Q3 2025 was $49.9 million at Global Indemnity, down from $52.9 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $337.5 million in Q4 2022 and troughed at -$207.8 million in Q4 2023.
  • A 5-year average of $24.4 million and a median of $11.2 million in 2021 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: soared 2916.98% in 2022 and later crashed 161.57% in 2023.
  • Year by year, Cost of Revenue stood at $11.2 million in 2021, then soared by 2916.98% to $337.5 million in 2022, then plummeted by 161.57% to -$207.8 million in 2023, then surged by 35.64% to -$133.8 million in 2024, then surged by 137.29% to $49.9 million in 2025.
  • Business Quant data shows Cost of Revenue for GBLI at $49.9 million in Q3 2025, $52.9 million in Q2 2025, and $66.7 million in Q1 2025.